Engineering cytokines for cancer immunotherapy: a systematic review

por Fu, Yong, Tang, Renhong, Zhao, Xiaofeng
Publicado 2023

The Correlation and Influencing Factors of Crisis Response Ability and Psychological Factors in Patients with Liver Cirrhosis

por JI, Yanping, DING, Qingbin, LI, Tingting, TANG, Renhong, ZHANG, Jing
Publicado 2020

All-trans retinoic acid stimulates the secretion of TGF-β2 via the phospholipase C but not the adenylyl cyclase signaling pathway in retinal pigment epithelium cells

por Zhang, Daren, Deng, Zhihong, Tan, Jia, Liu, Shuirong, Hu, Shuyu, Tao, Hui, Tang, Renhong
Publicado 2019

Novel compound heterozygous mutations in the CHST6 gene cause macular corneal dystrophy in a Han Chinese family

por Huang, Yanxia, Yuan, Lamei, Cao, Yanna, Tang, Renhong, Xu, Hongbo, Tang, Ziqian, Deng, Hao
Publicado 2021

Viability of primary cultured retinal neurons in a hyperglycemic condition

por Liu, Yu, Xu, Xueliang, Tang, Renhong, Chen, Guoping, Lei, Xiang, Gao, Limo, Li, Wenjie, Chen, Yu
Publicado 2013

RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in...

por Chen, Yizhi, Tang, Renhong, Xiong, Wei, Zhang, Feng, Wang, Nuo, Xie, Bingyu, Cao, Jiamin, Chen, Zhuokun, Ma, Chen
Publicado 2023

A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents

por Guo, Leilei, Qin, Xiaokang, Xue, Liting, Yang, Janine Y., Zhang, Yumei, Zhu, Shunwei, Ye, Gang, Tang, Renhong, Yang, WenQing
Publicado 2022

SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models

por Zhou, Feng, Yang, Guimei, Xue, Liting, Liu, Yajing, Guo, Yao, Zhu, Ji, Yuan, Linlin, Gu, Peng, Tang, Feng, Shan, Jinwen, Tang, Renhong
Publicado 2023

Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment

por Xue, Liting, Gao, Xingyuan, Zhang, Haoyu, Tang, Jianxing, Wang, Qian, Li, Feng, Li, Xinxin, Yu, Xiaohong, Lu, Zhihong, Huang, Yue, Tang, Renhong, Yang, Wenqing
Publicado 2021

Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors

por Gu, Peng, Xue, Liting, Zhao, Chunyan, Li, Wenjing, Jiang, Zhen, Liu, Aiguo, Li, Tingting, Liu, Lu, Decker, Markus, Cheng, Xiaoxuan, Yang, Wenqing, Tang, Renhong
Publicado 2022

Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial

por Wang, Fuxiang, Xiao, Wen, Tang, Yimin, Cao, Mengli, Shu, Dan, Asakawa, Tetsuya, Xu, Yechun, Jiang, Xiangrui, Zhang, Leike, Wang, Wei, Tang, Jianxing, Huang, Yuansheng, Yang, Yang, Yang, Yumei, Tang, Renhong, Shen, Jingshan, Lu, Hongzhou
Publicado 2023

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir

por Jiang, Xiangrui, Su, Haixia, Shang, Weijuan, Zhou, Feng, Zhang, Yan, Zhao, Wenfeng, Zhang, Qiumeng, Xie, Hang, Jiang, Lei, Nie, Tianqing, Yang, Feipu, Xiong, Muya, Huang, Xiaoxing, Li, Minjun, Chen, Ping, Peng, Shaoping, Xiao, Gengfu, Jiang, Hualiang, Tang, Renhong, Zhang, Leike, Shen, Jingshan, Xu, Yechun
Publicado 2023